Mifepristone for Treatment of Uterine Leiomyoma: A Prospective Randomized Placebo Controlled Trial EDITORIAL COMMENT

M. Engman, S. Granberg, A. R. W. Williams, C. X. Meng, P. G. L. Lalitkumar, K. Gemzell-Danielsson

Research output: Contribution to journal › Editorial › peer-review

Original language	English
Pages (from-to)	99-101
Number of pages	3
Journal	Obstetrical & Gynecological Survey
Volume	65
Issue number	2
Publication status	Published - Feb 2010

Cite this

@article{81a0c32c67b94db782408539c090b99c,

title = "Mifepristone for Treatment of Uterine Leiomyoma: A Prospective Randomized Placebo Controlled Trial EDITORIAL COMMENT",

author = "M. Engman and S. Granberg and Williams, {A. R. W.} and Meng, {C. X.} and Lalitkumar, {P. G. L.} and K. Gemzell-Danielsson",

year = "2010",

month = feb,

language = "English",

volume = "65",

pages = "99--101",

journal = "Obstetrical & Gynecological Survey",

issn = "0029-7828",

publisher = "Lippincott, Williams & Wilkins",

number = "2",

}

TY - JOUR

T1 - Mifepristone for Treatment of Uterine Leiomyoma: A Prospective Randomized Placebo Controlled Trial EDITORIAL COMMENT

AU - Engman, M.

AU - Granberg, S.

AU - Williams, A. R. W.

AU - Meng, C. X.

AU - Lalitkumar, P. G. L.

AU - Gemzell-Danielsson, K.

PY - 2010/2

Y1 - 2010/2

M3 - Editorial

SN - 0029-7828

VL - 65

SP - 99

EP - 101

JO - Obstetrical & Gynecological Survey

JF - Obstetrical & Gynecological Survey

IS - 2

ER -